After months of uncertainty and controversy, the FDA has given approval to Sarepta's Duchenne muscular dystrophy drug – even though it hasn't yet shown any proof it can slow progress of the ...
The U.S. FDA approved 15 drugs in October ... exceeding last year’s average of 16, 2022’s 12.5, and the 17-per-month averages recorded in both 2021 and 2020.
“Nevertheless, drug developers invest in new medicines because, if their investments succeed, FDA’s rigorous drug approvals and ... to get since the 2016 and 2021 alterations significantly ...